Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)

NCT04402515 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped not due to safety reasons

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: TIO/OLO
DRUG: ICS

Sponsor

Boehringer Ingelheim